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Abstract 28 
In this study, a desorption electrospray ionization-high resolution mass 29 
spectrometry (DESI-HRMS) screening method was developed for fast identification of 30 
veterinary drugs in cross-contaminated feedstuffs. The reliable detection was performed 31 
working at high resolution (70,000 full with half maximum, FWHM) using an orbitrap 32 
mass analyser. Among the optimized DESI parameters, the solvent (acetonitrile-water, 33 
80:20, v/v) and the sample substrate (poly-tetrafluoroethylene, PTFE) were critical to 34 
obtain the best sensitivity. To analyse the solid feed samples, different approaches were 35 
tested and a simple solid-liquid extraction and the direct analysis of an aliquot (2 µL) of 36 
the extract after let it dry on the PTFE printed spot provided the best results. The 37 
identification of the veterinary drugs (target and non-target) in the cross-contaminated 38 
feedstuffs based on the accurate mass measurement and the isotopic pattern fit was 39 
performed automatically using a custom-made database. The positive cross-40 
contaminated feed samples were quantified by ultra-high performance liquid 41 
chromatography-tandem mass spectrometry (UHPLC-MS/MS). The results obtained 42 
demonstrate that DESI-HRMS can be proposed as a fast and suitable screening method 43 
to identify positive cross-contaminated feedstuffs reducing the number of samples to be 44 
subsequently quantified by UHPLC-MS/MS thus improving the productivity in quality 45 
control laboratories.  46 
 47 
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1. Introduction 58 
One of the most effective ways for farmers to administer medicines to the 59 
livestock after veterinary prescription is by medicated feed. The production and 60 
marketing of medicated feed are regulated by the European Commission [1] and many 61 
European countries have implemented residue monitoring plans to control the illegal 62 
use of these substances in feed and the misuse of authorised veterinary medicines, and 63 
to minimise drug residual occurrence [2]. The European Parliament and the Council of 64 
the European Union have established, under the Regulation 183/2005/EC, the general 65 
rules to control feed production and their manufacturing conditions, thus ensuring the 66 
traceability of feed [3]. Despite the requirements set for feed business, multi-product 67 
plants manufacture both medicated and non-medicated feed in the same production line 68 
[4, 5] and, under practical conditions, during the production a certain percentage of the 69 
previous batch remains in the production circuit contaminating the subsequent feed 70 
batch. This “carry-over” or “cross-contamination” is recognized by the Current Good 71 
Manufacturing Practice Regulations (CGMPR) which requires adequate clean-out 72 
procedures to prevent the “unsafe” contamination. This cross-contamination may result 73 
in the exposure of non-target animals and, as a consequence, potential health risks for 74 
these animals as well as the presence of residue contamination in food products might 75 
occur. Several studies have shown that production of premixes and composed feed free 76 
of contamination is, in practice, very difficult in the existing multi-product plants [5]. If 77 
the drug carry-over results in the unsafe contamination of other medicated or non-78 
medicated feed, it constitutes a violation of the maximum limits established by 79 
Directive 574/2011/EC [6], resulting in adulterated feed.  80 
To increase the productivity in agricultural and food laboratories the rapid 81 
screening of (il)legal preparations to identify veterinary drugs in feedstuffs is widely 82 
demanded [7–13]. Today, liquid chromatography coupled to tandem mass spectrometry 83 
(LC-MS/MS) is the technique most currently used for the determination of drug 84 
contamination in feed samples. However, the complexity of feed samples requires 85 
extensive and time-consuming sample treatment protocols to provide clean extracts to 86 
be analyzed by the selective target LC-MS/MS methods [9, 10, 12–16]. In the last 87 
decade, the introduction of high resolution mass spectrometry (HRMS) has improved 88 
selectivity and specificity of LC-MS methods. However, only few methods have been 89 
published until now regarding the analysis of feed samples by LC-HRMS [17–19].  90 
The recent introduction of ambient ionization techniques in mass spectrometry 91 
such as desorption electrospray ionization (DESI) [20] and direct analysis in real time 92 
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(DART) [21] open the possibility for the direct analysis of compounds from the sample 93 
acquiring the mass spectra from bulk samples in their native state and without sample 94 
treatment or chromatographic separation [22, 23]. The analysis is performed in few 95 
seconds, which is a significant advantage when compared to conventional analytical 96 
methods. Particularly, in DESI a spray of charged liquid droplets is directed to the 97 
sample creating a solvent film on the surface. Further droplets hit this film splashing 98 
secondary droplets containing the analytes into the mass spectrometer [25]. Since their 99 
introduction, ambient techniques have been applied to multitude of fields, such as 100 
environmental [24–26], food [27–29], clinical diagnosis [30] and forensic analysis [31]. 101 
Nevertheless, only few papers described the use of ambient techniques for the analysis 102 
of veterinary drugs [33, 34]. DESI-MS has been applied for a rapid screening of 103 
hormones and veterinary drugs in samples from forensic investigations using an ion trap 104 
(IT) mass analyzer, although authors indicated the difficulty to detect tetracyclines 105 
under the DESI-MS conditions used [32]. Moreover, DART-HRMS has been applied 106 
for the target analysis of coccidiostats in feed samples using an orbitrap mass analyser 107 
demonstrating the feasibility of this ambient technique to quantify these analytes at the 108 
levels established by the EU legislation [33]. 109 
The aim of this work is to study the applicability of DESI coupled to HRMS 110 
(orbitrap) for the fast screening of veterinary drugs in cross contaminated feed samples 111 
in order to improve throughput analysis and productivity of feed control laboratories. 112 
For this purpose, the most critical DESI-HRMS working parameters are evaluated and 113 
discussed. A home custom made database with mass spectral information of veterinary 114 
drugs is used for the fast identification of target compounds and suspect cross-115 
contaminants.  116 
 117 
2. Experimental 118 
2.1 Chemicals and materials 119 
Nine veterinary drugs were used as model standards for the optimization of 120 
DESI parameters. Diclazuril (DIC), narasin (NAR), monensin (MON) oxibendazole 121 
(OXI), amoxicillin (AMO), lincomycin (LIN), tiamulin (TIA) and spiramycin (SPI) 122 
were purchased from Sigma-Aldrich (Steinheim, Germany) while tylosin (TYL) was 123 
purchased from Rikilt (Wageningen, Netherlands). All the standards were of the highest 124 
purity available. LC-MS grade methanol (MeOH), acetonitrile (ACN) and water were 125 
supplied by Sigma-Aldrich (Steinheim, Germany) as well as formic acid (≥99%). 126 
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Nitrogen (99.9995% purity) used for nebulization gas was supplied by Linde Group 127 
(Barcelona, Spain). Individual stock solutions (1 mg mL-1) were prepared in MeOH and 128 
stored at 4°C, while the working standard mixtures were prepared weekly by 129 
appropriate dilution in ACN. 130 
 131 
2.2 Desorption Electrospray Ionization-High Resolution Mass Spectrometry 132 
A desorption electrospray ionization (DESI) source (Omnispray Ion Source, 133 
Prosolia Inc., Indianapolis, IN) equipped with an 1D moving stage and coupled to a 134 
quadrupole-orbitrap mass spectrometer (Q-Exactive, Thermo Fisher Scientific, San 135 
José, CA, USA) was used in this study. DESI solvent (acetonitrile:water, 80:20 v:v) was 136 
infused by a syringe pump at 2.5 µL min-1 and N2 gas was used as nebulizer gas at a 137 
pressure of 9 bar. DESI solvent was directed onto the sample surface at a nebulization 138 
capillary angle of 55° and a distance of ~9.2 mm between the mass spectrometer inlet 139 
and the spray tip. The electrospray voltage was ±4.8 kV (positive/negative). The 140 
transfer capillary temperature was set at 250°C. Samples were deposited onto 141 
microscope glass slides of 7.1 mm2 polytetrafluoroethylene (PTFE) (Teflon, McMaster-142 
Carr, Santa Fe, CA, USA) printed spots. The Q-Exactive mass spectrometer was 143 
operated in positive and negative ion mode within an m/z scan range of 100-1,000 m/z. 144 
Omni Spray ion source software v2.0 (Omnispray Ion Source, Prosolia Inc., 145 
Indianapolis, IN) was used to control the DESI source, while data acquisition and data 146 
processing were performed with Xcalibur software v2.2 and Exact Finder software v2.0 147 
(Thermo Fisher Scientific, San José, CA, USA), respectively. 148 
To control the reproducibility and to determine the initial DESI conditions, a red 149 
permanent marker (containing rhodamine-6G dye) purchased from Fine Sharpie 150 
(Stanford Corp., Oak Brook, IL) was used. Accurate mass calibration was performed in 151 
the Q-Exactive mass spectrometer every 48 h in both positive and negative ion modes. 152 
For positive ion mode a calibration solution consisting of caffeine, MRFA peptide, 153 
Ultramark 1621 and n-butylamine in acetonitrile/methanol/water containing 1% formic 154 
was used, while for negative ion mode calibration a mixture solution containing dodecyl 155 
sulface, sodium taurocholate and Ultramark 1621 in acetonitrile/methanol/water with 156 
1% of formic acid was used.  157 
 158 
2.3 Samples and sample preparation 159 
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Feed samples, collected from farms and feed mills, that were received by the 160 
Laboratori Agroalimentari of the Generalitat de Catalunya (LAC) for their analysis by 161 
UHPLC-MS/MS [10] were used to demonstrate the applicability of the DESI-HRMS in 162 
this study. 163 
Feed samples were extracted using a simple and fast solid-liquid extraction 164 
procedure. Briefly, 2 g of the sample were placed in a 15-mL polypropylene centrifuge 165 
tube and were extracted for 15 min in an ultrasonic bath (Bransonic B-5510, Soest, 166 
Germany) using 5 mL of a mixture of acetonitrile/water (80:20, v/v) acidified with 1% 167 
formic acid. Finally, the extract was centrifuged (Selecta-Macrotronic, J.P. SELECTA 168 
S.A, Abrera, Spain) for 1 min at 3,500 rpm and 2 µL of the supernatant were deposited 169 
onto the PTFE printed spot and let it dry for 5 min at ambient temperature before the 170 
DESI-HRMS analysis.  171 
 172 
3. Results and discussion 173 
3.1 DESI-HRMS 174 
Nine veterinary drugs (macrolides, coccidiostats, and benzimidazoles) were used 175 
as model compounds to evaluate and to set up the DESI-HRMS working conditions. 176 
Standard solutions in pure acetonitrile (10 µg mL-1) were deposited on PTFE surfaces 177 
and DESI full mass spectra were recorded using both positive and negative ion modes. 178 
Fig. 1 shows the mass spectra obtained for a standard mixture where MON, NAR, TIA, 179 
TYL, ESP, LIN and OXI were detected in positive ion mode mainly as protonated 180 
molecules [M+H]+, except MON and NAR for which sodium adducts [M+Na]+ were 181 
observed. Regarding DIC and AMOX, they were only detected in negative ion mode as 182 
deprotonated molecules [M-H]-. Additionally, the DESI-HRMS analysis of individual 183 
standard solutions indicated that no significant in-source CID fragmentation and other 184 
adducts formation were expected for these compounds, allowing us to assign one ion 185 
(isotope cluster) to each veterinary drug during the screening. 186 
The DESI-HRMS screening of veterinary drugs in feed samples was based on 187 
the accurate mass measurement and the isotope pattern distribution of the detected ions. 188 
Orbitrap can operate at a mass resolution high enough to prevent possible endogenous 189 
matrix interferences without sacrificing sensitivity. However, a compromise between 190 
acquisition duty cycle and mass resolution was necessary to provide both accurate mass 191 
measurements with mass errors below 5 ppm and enough sensitivity to detect the 192 
analytes in the complex mass spectrum. To select the working mass resolution, a blank 193 
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sample extract spiked with the nine veterinary drugs (10 µg mL-1) was analyzed at 194 
values between 17,500 and 140,000 FWHM (full width half maximum). All target 195 
compounds showed a drop in sensitivity when working above 70,000 without any 196 
significant improvement in mass accuracy. Thus, this mass resolution was used for 197 
further screening analysis.  198 
Moreover, the sensitivity of the DESI-HRMS method also depended on the 199 
number of ions accumulated inside the orbitrap and also on the accumulation time 200 
applied. Since the automatic gain control (AGC) algorithm controls the number of ions 201 
inside the orbitrap to prevent space charge effects, the injection time (accumulation 202 
time) had to be optimized. Thus, the AGC was kept constant at 1 x 106 and the injection 203 
time was varied between 50 and 500 ms. The best signal was obtained for 300 ms as 204 
injection time. This relatively high injection time compared to conventional ESI is due 205 
to the low ion intensity generated in the DESI process that required longer injection 206 
times to accumulate a number of ions high enough to obtain a reasonable spectrum.  207 
 208 
3.2. Optimization of DESI working conditions  209 
To maximize the DESI signal, two main groups of working conditions must be 210 
optimized. The first group comprises those conditions related to the electrospray 211 
process such as nebulizing gas pressure, electrospray solvent composition, electrospray 212 
solvent flow rate and the substrate/surface. The second group is related to the 213 
geometrical DESI parameters that include the nebulization capillary angle, the tip 214 
distance to the sample surface and the distance to the mass spectrometer inlet. Initial 215 
DESI conditions were established using rhodamine-containing marker and the most 216 
critical DESI ion source parameters (nebulization capillary angle, tip distance to the 217 
sample surface, distance to mass spectrometer inlet, nebulizing capillary gas, solvent 218 
flow rate and capillary voltage) were individually optimized using blank feed extracts 219 
spiked with a set of veterinary drugs (10 µg g-1).  220 
It has been demonstrated that the sample surface (substrate) plays a crucial role 221 
in DESI performance. Since the DESI process involves the landing and release of 222 
charged particles on a surface, the fundamental features of the solid surface, including 223 
its chemical composition and texture, severely affect the energy and charge transfer 224 
processes and consequently the ionization efficiency in DESI. Thus, several important 225 
parameters such as limit of detection, signal stability, carryover and reproducibility of 226 
the DESI method can be influenced by the surface [34]. In this work, three different 227 
surfaces were tested as substrates to analyze spiked acetonitrile feed extracts: glass, 228 
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filter paper and PTFE. The highest and most stable signal was observed when using the 229 
PTFE surface. In filter paper worse reproducibility than in PTFE was obtained, which 230 
can be due to uneven distribution of the analytes on the surface caused by 231 
chromatographic effects that occur in the course of the solution deposition [35]. 232 
DESI solvent composition and analyte solubility in the DESI solvent have an 233 
important effect in both desorption and transfer of analytes from the surface to the mass 234 
spectrometer. DESI solvent composition strongly affects electrospray droplets 235 
formation influencing the primary droplets size and the droplets charge, as well as the 236 
focus of the spray. Additionally, DESI solvent composition could favor the extraction 237 
and electrospray ionization of the analyte. To select the most adequate DESI solvent, 238 
different solvent mixtures of methanol:water and acetonitrile:water and the addition of 239 
formic acid to promote the protonation of target compounds in positive ion mode were 240 
evaluated. As an example, the effect of the DESI solvent composition on the ion signal 241 
intensity of MON, NAR and TIA in positive ion mode and DIC in negative ion mode is 242 
depicted in Fig. 2a. As can be seen, the composition of the DESI solvent dramatically 243 
affects the compounds signal. The highest signal intensity, in both positive and negative 244 
ion modes, was achieved when using acetonitrile:water. The increase in the compound 245 
response may be due to the higher solubility of the analytes in the acetonitrile:water 246 
solvent that improves the transfer efficiency of the analytes into the secondary ESI 247 
droplets. It should be noted that an important decrease on the relative abundance of the 248 
ions generated from the veterinary drugs was observed when adding formic acid to the 249 
DESI solvent (Fig. 2a). These results were expected for veterinary drugs such as MON 250 
and NAR because the ion abundance of [M+Na]+, the base peak in the non-acidic DESI 251 
solvent, can decrease due to the competition with [M+H]+ ion generated in acidic 252 
medium. For acidic compounds that ionized in negative ion mode generating 253 
deprotonate molecules [M-H]-, the ion signal also decreased when using acid in the 254 
DESI solvent because the neutral species are favored in the liquid phase. However, 255 
unexpected results were observed for basic compounds such as TIA, for which the 256 
acidic media should facilitate the protonation of analytes in positive-ion mode.  This 257 
might be due to an increase in the DESI droplet size caused by the enhancement of the 258 
surface tension produced by the higher ionic strength of the acidic DESI solvent (formic 259 
acid), in agreement with the results obtained by Green et al. [36]. Moreover, the effect 260 
of the organic solvent percentage of the DESI solvent on the ion signal intensity was 261 
also studied. The ion abundances observed for each compound using different 262 
acetonitrile:water mixtures are shown in Fig. 2b. All compounds studied showed a 263 
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similar behavior. The ion signal intensity increased when increasing the organic solvent 264 
content from 50% to 80%. This could be explained by the highest solubility of the 265 
analytes in the enriched acetonitrile solvent mixture. Nevertheless, the ion signal 266 
intensity dropped when using 90-100% acetonitrile probably due to a worse wettability 267 
of the surface when using a solvent with lower hydrophilicity (> 90% acetonitrile). The 268 
optimal conditions, acetonitrile:water 80/20 (v/v), were supposed to be satisfactory for 269 
the other veterinary drugs with similar physicochemical properties to the chemicals 270 
studied.  271 
The DESI solvent flow rate and nebulizing gas pressure affect the wetting and 272 
the flow dynamics on the surface as well as the size and velocity of the electrospray 273 
droplets, thus playing an important role in both ionization and desorption of analytes 274 
from the surface [37]. In this study, these parameters were optimized using the 275 
previously selected DESI solvent (acetonitrile:water 80/20, v/v). The gas pressure was 276 
tested within the range of 7-10 bars and it was observed that when working at gas 277 
pressure values below 9 bars the intensity dropped. This might be due to the formation 278 
of electrospray droplets of slow velocity and to the generation of secondary droplets 279 
with less kinetic energy to escape from the surface. In contrast, when applying a gas 280 
pressure of 10 bars the signal also dropped probably because the high gas flow rate 281 
pushed the secondary droplets back to the surface leading to enhance droplet splashing. 282 
Regarding DESI solvent flow rate, it was varied from 1 to 5 µL min-1 and it was 283 
observed that when increasing flow rate the signal improved probably due to the better 284 
surface wetting. Nevertheless, a wider surface area was eroded thus worsening the 285 
spatial resolution [38]. As a compromise between sensitivity and spatial resolution a gas 286 
pressure of 9 bars and a DESI solvent flow rate of 2.5 µL min-1 were choose as optimal 287 
working conditions.  288 
To optimize the geometrical parameters we used acetonitrile:water (80/20, v/v) 289 
as DESI solvent. The position of the spray tip (both within the spray head and relative to 290 
the surface area) is critical for a successful DESI signal. Thus, the nebulizing capillary 291 
angle (α) and the tip distance to the sample surface (d1) have direct effects on the 292 
ionization process, while the distance to the mass spectrometer inlet (d2) have important 293 
effects on the ion collection efficiency and, hence, on the sensitivity of the method. The 294 
effect of α on the DESI signal was evaluated by modifying the incident angle (45º-75º) 295 
of the electrospray tip relative to the surface that changes the impact angle of the 296 
droplets on the surface. The highest intensity was observed for an α value of 55°, which 297 
is generally used as optimum value in other DESI applications [39]. The d1 and d2 298 
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values were varied from 1.5 to 4 mm and from 4 to 10 mm, respectively. For a DESI 299 
solvent flow rate of 2.5 µL min-1 the closer was the sprayer to the surface (d1), the 300 
highest was the signal, being 1.7 mm the optimal value for all the analytes. Moreover, 301 
for d2 the best response was observed at 5 mm when analyzing the spiked feed extract. 302 
 303 
3.3. DESI-HRMS analytical performance. 304 
The complexity of the matrix and the wide polarity range among the different 305 
chemical groups of the veterinary drugs make the analysis of feedstuffs a challenge. 306 
Different sample manipulation strategies were evaluated to screen veterinary drugs in 307 
feed. Because of the powder nature of the feed samples studied, the direct analysis by 308 
DESI-HRMS was not possible. As a first attempt, we prepared pressed feed pellets of 309 
1.5 cm in diameter using a manual hydraulic press to get a smooth surface to be 310 
screened by DESI-HRMS. However, the dusty texture of the feed samples made 311 
difficult to obtain good results because of the damaging of the feed pellet surface by the 312 
nebulizing gas and the contamination of the mass spectrometer transfer line by the 313 
powdery sample. To enhance the pellets compactness different pressures (from 10 to 15 314 
tons) were tested as well as the addition of boric acid to increase pellet agglutination, 315 
although no significant differences were observed.  316 
As an alternative to the direct analysis of the sample surface, a simple solid-317 
liquid extraction procedure was considered. Several sample extraction multi-analyte 318 
methods based on organic solvent mixtures have been developed for the detection of a 319 
wide range of veterinary drugs in animal feed by LC/MS [12, 13, 17, 40] manly using 320 
acetonitrile and methanol. Hence, the behaviour of both solvents for the analysis by 321 
DESI of feed samples was tested. For this purpose,  blank feed extracts extracted 322 
individually with these solvents and spiked with the nine representative veterinary drugs 323 
(10 µg g-1) were deposited onto a PTFE surface after let it dry and were analysed by 324 
DESI-HRMS. The results showed that higher ion intensities were obtained when using 325 
acetonitrile as extraction solvent since methanol may extract too many matrix 326 
compounds that can cause ion suppression. In contrast, acetonitrile allows protein 327 
precipitation and enzyme denaturation resulting in cleaner extracts. However, it has 328 
been described that the use of only organic solvents (acetonitrile, methanol or 329 
combination of both) at different percentages, led to low intensities for non-ionophore 330 
coccidiostats (clopidol, ethopabate, amprolium), macrolides and tetracyclines [41]. 331 
Moreover, some authors recommend the addition of a small amount of water, up to 332 
20%, to the organic solvent to favour the extraction of polar compounds [40].  So, 333 
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acetonitrile/water (80/20, v/v) with 1% of formic acid recommended to increase the 334 
extraction of basic compounds was chosen as extraction solvent for the DESI-HRMS 335 
multi-residue method. 336 
The effect of the feed matrix in the ionization efficiency was tested for the nine 337 
representative veterinary drugs. A blank feed extract was spiked at 10 µg g-1 level and 338 
then extracted with acetonitrile:water (80/20, v/v) with 1% formic acid. The mass 339 
spectra of this spiked blank feed extract and that obtained for a standard mixture at the 340 
same concentration level prepared in acetonitrile:water (80/20, v/v) with 1% formic acid 341 
were compared. For all the studied compounds, the ion signal in the spiked feed blank 342 
extracts were one order of magnitude lower than in the standard mixture indicating that 343 
ion suppression occurs. Even though, limits of detection (LODs) estimated for the tested 344 
compounds were lower than 1 µg g-1 (Table 1), except for amoxicillin, for which a 345 
higher estimated LOD value (15 µg g-1) was obtained, probably because of a partial 346 
degradation in acidic solutions, especially at low concentration levels [2]. LODs, based 347 
on a signal-to-noise ratio of 3:1, were estimated by analyzing blank feed samples spiked 348 
with standards at low concentrations. For those compounds that the standard was not 349 
available, LODs from sample were calculated taking into account a signal-to-noise ratio 350 
of 3:1 and the concentration levels of veterinary drugs quantified by HPLC-MS/MS. 351 
These values are below the legal limits legislated for most of the veterinary drugs due to 352 
the unavoidable carry-over in the line production (µg g-1 levels) except for diclazuril, 353 
which the maximum residue level is legislated at 0.01 µg g-1  [6]. 354 
 355 
3.4. DESI-HRMS screening of feed samples 356 
To evaluate the applicability of the developed DESI-HRMS method, 50 feed 357 
samples (medicated and no medicated feed) received from LAC were analysed using the 358 
DESI-HRMS method in order to detect those samples suspected of being cross-359 
contaminated by veterinary drugs.  360 
Feed samples were screened and the acquired mass spectral raw data were 361 
interrogated by a custom-made database that included more than 60 veterinary drugs 362 
(anthelmintics, antibiotics, coccidiostats, hormones, etc.) commonly used to produce 363 
medicated feedstuffs. For each substance, the compound name, the CAS number, the 364 
elemental composition and the chemical structure were included. The ionization mode 365 
and the expected ions (protonated and deprotonated molecules, adduct ions, in-source 366 
fragments, etc.) that can be generated in the DESI source were also added to the 367 
custom-made database.  368 
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Feed samples (three replicates) were submitted to the simple sample treatment 369 
detailed in the experimental section and analysed by the DESI-HRMS multi-reside 370 
method. The sample raw data files were processed using the Exact Finder software and 371 
interrogated by the custom-made database to automatically identify the veterinary drugs 372 
in the feedstuffs. The criteria applied to confirm the presence of the suspected 373 
compounds were the following: a mass accuracy of less than 5 ppm on the exact mass, a 374 
minimum signal-to-noise ratio of 3:1 and an isotope cluster fit higher than 80% (both 375 
mass relative deviation and relative intensity differences, for each isotope peak within 376 
the cluster ion, were taken into account). Feed samples were also analysed by a well-377 
established UHPLC-MS/MS method for the quantification of the identified compounds 378 
[10].  379 
Table 1 lists the positive samples and the veterinary drugs identified along with 380 
the DESI-HRMS identification criteria and the quantitative results obtained by target 381 
UHPLC-MS/MS method. The veterinary drugs at dose levels between 37-107 µg g-1 in 382 
the medicated feed were easily detected by the DESI-HRMS screening method and only 383 
in one of these samples (MF5) an unexpected cross-contamination of monensin (3.5 µg 384 
g-1) was detected. Fig. 3 shows the DESI-HRMS spectrum of a naransin medicated feed 385 
where both narasin and monensin were identified. Additionally, results obtained for 386 
non-medicated feed indicated that cross-contamination occurs quite frequently and 387 
values above the legislated levels were detected in 28% of the samples analysed by 388 
DESI-HRMS. Coccidiostats (monensin, narasin, decoquinate, nicarbazin, salinomycin 389 
and lasalocid), benzimidazoles (oxibendazole), amphenicols (florfenicol), tetracyclines 390 
(doxycycline and tetracycline), lincosamides (lincomicyn) and pleuromutilins (tiamulin) 391 
were identified in the non-medicated feed samples at concentration levels ranging from 392 
29 to 1.3 µg g-1. For most of these samples, the cross-contamination was at 393 
concentration levels close to the maximum residue levels, except for sample BF2, where 394 
salinomycin was detected at 20 µg g-1, a third of the minimum dose recommended for a 395 
medicated feed (60 µg g-1) [42]. Furthermore, in most of the non-medicated feeds 396 
several veterinary drugs were detected in the same sample. For instance, sample BF11 397 
was cross-contaminated with tiamulin (1.7 µg g-1) and doxycycline (7.2 µg g-1) and in 398 
sample BF13 monensin and narasin (at <µg g-1 level) were positively identified. The 399 
UHPLC-MS/MS analysis of the whole set of samples confirmed the DESI-HRMS 400 
results and also allowed the identification of additional veterinary drugs at sub-µg g-1 401 
level. However, these low concentration levels are much lower than the maximum 402 
residue levels and they are considered unavoidable carry-over.  403 
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Regarding the obtained results, the developed DESI-HRMS method could be 404 
suitable to detect cross-contamination of veterinary drugs in feed samples in quality 405 
control laboratories since it is simple, with minimum sample manipulation, less time 406 
consuming and able to detect cross-contamination at the maximum residue levels 407 
legislated. 408 
 409 
4. Conclusions 410 
DESI-HRMS has been shown to be an effective approach for the screening of 411 
veterinary drugs in cross-contaminated feedstuffs. A minimal sample manipulation 412 
based on a simple extraction procedure (acetonitrile:water 80:20 v/v acidified with 1% 413 
formic acid) is proposed to analyse dusty homogenised feed samples. Among the DESI 414 
working parameters optimized using nine representative veterinary drugs, the most 415 
critical ones for the feed extract analysis were the substrate and the DESI solvent. PTFE 416 
substrate and acetonitrile:water (80:20 v/v) as DESI solvent provided the highest signal 417 
intensity. Although ion suppression due to matrix effects was observed, the sensitivity 418 
achieved by DESI-HRMS was enough to identify veterinary drugs as cross-419 
contamination above the legislated levels. Data acquired in high resolution mass 420 
spectrometry (70,000 FWHM), processed and interrogated with the custom-made 421 
database provided the identification of cross-contamination of non-target veterinary 422 
drugs based on accurate mass measurements and isotope cluster fit from HRMS full 423 
scan spectra. The results obtained in the feed sample analysis correlated well with those 424 
found by UHPLC-MS/MS and demonstrate the potential of the DESI-HRMS as 425 
screening method to identify cross-contaminated feedstuffs reducing the number of 426 
samples to be quantified by UHPLC-MS/MS in quality control laboratories.  427 
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Figure captions 576 
Fig. 1 DESI-HRMS (+/-) full-scan mass spectrum of a standard mixture with nine representative 577 
veterinary drugs. DESI solvent: acetonitrile/water (80:20, v/v); sample volume: 2 µL; sample 578 
substrate: PTFE 579 
Fig. 2 Effect of the DESI solvent nature (a) and the percentage of acetonitrile in the DESI-580 
HRMS signal for some representative veterinary drugs 581 
Fig. 3 DESI-HRMS full scan spectrum obtained from a narasin (NAR) medicated feed (37 µg g-582 
1) cross-contaminated with monensin (MON) (3.5 µg g-1) 583 
 584 
 585 
  586 
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Table 1. Screening results 587 
   588 
a Maximum residue levels legislated in Directive 574/2011/EC. 589 
b Limits of Detection (LOD) calculated by DESI-HRMS 590 
c LODs estimated by spiking blank feed extracts with standards 591 
d LODs calculated taking into accound the concentration level quantified by HPLC-MS/MS 592 
* (MRL) 593 
  
 DESI-HRMS 
screening 
UHPLC-MS/MS 
quantification 
(MRL)a  
Sample Detected 
antibiotics 
LODb 
(µg g-1) 
Exact mass 
(m/z) 
Accurate 
mass 
(m/z) 
Ion 
assignment 
Elemental  
composition 
Mass 
accuracy 
(ppm) 
Isotopic 
cluster 
fit (%) 
(µg g-1) 
Medicated feed         
MF1 Lincomycin  407.2210 407.2205 [M+H]+ (C18H35N2O6S) 1.3 95 107 
MF2 Monensin  693.4184 693.4169 [M+Na]+ (C36H62O11Na) 2.2 89 100 
MF3 Monensin  693.4184 693.4184 [M+Na]+ (C36H62O11Na) 0.1 92 87 
MF4 Narasin  787.4967 787.4947 [M+Na]+ (C43H72O11Na) 2.5 88 44 
MF5 Narasin  787.4967 787.4952 [M+Na]+ (C43H72O11Na) 1.9 84 37 
Monensin 0.5 c 693.4184 693.4167 [M+Na]+ (C36H62O11Na) 2.5 80 3.5* (1.25) 
Non-medicated feed         
BF1 Florfenicol 0.7 d 379.9897 379.9891 [M+Na]+ (C12H14Cl2FNO4SNa) 1.5 80 7.0 
BF2 Salinomycin 0.7 d 773.4810 773.4794 [M+Na]+ (C42H70O11Na) 2.1 86 20* (0.7) 
Amoxcillin 15 c 364.0973 n.d. [M-H]- (C16H19O5N3S) ---- ---- 0.13 
Tiamulin 0.5 c 494.3299 n.d. [M+H]+ (C28H48NO4S) ---- ---- 0.11 
BF3 Oxytetracycline 0.5 c 461.1555 461.1546 [M+H]+ (C22H25N2O9) 1.9 93 6.3 
BF4 Decoquinate 0.4 d 440.2407 440.2412 [M+Na]+ (C24H35NO5Na) 1.1 91 5.0* (0.4) 
BF5 Decoquinate 0.4 d 440.2407 440.2410 [M+Na]+ (C24H35NO5Na) 0.5 89 3.3* (0.4) 
BF6 Lasalocid 0.4 d 613.3711 613.3705 [M+Na]+ (C34H54O8Na) 1.0 80 0.45 (1.25) 
Decoquinate  440.2407 n.d. [M+Na]+ (C24H35NO5Na) ---- ---- 0.21 (0.4) 
BF7 Narasin 0.5 c 787.4967 787.4957 [M+Na]+ (C43H72O11Na) 1.2 84 1.3* (0.7) 
BF8 Tiamulin 0.5 c 494.3299 494.3288 [M+H]+ (C28H48NO4S) 2.1 86 1.6 
Amoxicillin 15 c 364.0973 n.d. [M-H]- (C16H19O5N3S) ---- ---- 0.80 
BF9 Narasin 0.5 c 787.4969 787.4955 [M+Na]+ (C43H72O11Na) 1.5 89 2.1* (0.7) 
Nicarbazin  301.0573 n.d. [M-H]- (C19H18O6N6) ---- ---- 0.42 (1.25) 
BF10 Narasin 0.5 c 787.4969 787.4967 [M+Na]+ (C43H72O11Na) 1.3 91 29* (0.7) 
BF11 Tiamulin 0.5 c 494.3299 494.3297 [M+H]+ (C28H48NO4S) 0.4 83 1.7 
Doxycycline 1.2 c 463.1711 463.1714 [M+H]+ (C22H27N2O9) 0.6 94 7.2 
Amoxcillin 15 c 364.0973 n.d. [M-H]- (C16H19O5N3S) ---- ---- 2.0 
BF12 Decoquinate 0.4 d 440.2407 440.2413 [M+Na]+ (C24H35NO5Na) 1.2 88 5.0* (0.4) 
BF13 Narasin 0.5 c 787.4967 787.4964 [M+Na]+ (C43H72O11Na) 0.3 83 1.7* (0.7) 
Monensin 0.5 c 693.4184 693.4187 [M+Na]+ (C36H62O11Na) 0.3 84 1.6* (1.25) 
Robenidine  334.0621 n.d. [M+H]+ (C15H13Cl2N5) ---- ---- 0.32 (0.7) 
Diclazuril 1 c 404.9718 n.d. [M-H]- (C17H9Cl3O2N4) ---- ---- 0.01* (0.01) 
BF14 Amoxicillin 15 c 364.0973 n.d. [M-H]- (C16H19O5N3S) ---- ---- 0.17 
Tiamulin 0.5 c 494.3299 n.d. [M+H]+ (C28H48NO4S) ---- ---- 0.50 
BF15 Oxibendazole 0.5 c 250.1186 250.1188 [M+H]+ (C12H16N3O3) ---- ---- 0.13 
BF16 Amoxcillin 15 c 364.0973 n.d. [M-H]- (C16H19O5N3S) ---- ---- 0.17 
Lincomycin 0.5 c 407.2210 n.d. [M+H]+ (C18H35N2O6S) ---- ---- 0.25 
Oxibendazole 0.5 c 250.1186 n.d. [M+H]+ (C12H16N3O3) ---- ---- 0.20 
Tiamulin 0.5 c 494.3299 n.d. [M+H]+ (C28H48NO4S) ---- ---- 0.18 
BF17 Amoxcillin 15 c 364.0973 n.d. [M-H]- (C16H19O5N3S) ---- ---- 0.15 
Lincomycin 0.5 c 407.2210 n.d. [M+H]+
 
(C18H35N2O6S) ---- ---- 0.39 
BF18 Nicarbazin  301.0573 n.d. [M-H]- (C19H18O6N6) ---- ---- 0.16 (1.25) 
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